BLFS
Price
$24.80
Change
+$0.45 (+1.85%)
Updated
Apr 24 closing price
Capitalization
810.87M
13 days until earnings call
RCEL
Price
$9.89
Change
+$0.15 (+1.54%)
Updated
Apr 24, 04:59 PM (EDT)
Capitalization
399.48M
13 days until earnings call
Ad is loading...

BLFS vs RCEL

Header iconBLFS vs RCEL Comparison
Open Charts BLFS vs RCELBanner chart's image
BioLife Solutions
Price$24.80
Change+$0.45 (+1.85%)
Volume$455.25K
Capitalization810.87M
Avita Medical
Price$9.89
Change+$0.15 (+1.54%)
Volume$803
Capitalization399.48M
BLFS vs RCEL Comparison Chart
Loading...
BLFS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
RCEL
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
BLFS vs. RCEL commentary
Apr 25, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BLFS is a StrongBuy and RCEL is a StrongBuy.

Ad is loading...
COMPARISON
Comparison
Apr 25, 2025
Stock price -- (BLFS: $24.80 vs. RCEL: $9.89)
Brand notoriety: BLFS and RCEL are both not notable
Both companies represent the Medical Specialties industry
Current volume relative to the 65-day Moving Average: BLFS: 91% vs. RCEL: 34%
Market capitalization -- BLFS: $810.87M vs. RCEL: $399.48M
BLFS [@Medical Specialties] is valued at $810.87M. RCEL’s [@Medical Specialties] market capitalization is $399.48M. The market cap for tickers in the [@Medical Specialties] industry ranges from $3.82T to $0. The average market capitalization across the [@Medical Specialties] industry is $8.31B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

BLFS’s FA Score shows that 1 FA rating(s) are green whileRCEL’s FA Score has 0 green FA rating(s).

  • BLFS’s FA Score: 1 green, 4 red.
  • RCEL’s FA Score: 0 green, 5 red.
According to our system of comparison, both BLFS and RCEL are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

BLFS’s TA Score shows that 5 TA indicator(s) are bullish while RCEL’s TA Score has 6 bullish TA indicator(s).

  • BLFS’s TA Score: 5 bullish, 5 bearish.
  • RCEL’s TA Score: 6 bullish, 2 bearish.
According to our system of comparison, RCEL is a better buy in the short-term than BLFS.

Price Growth

BLFS (@Medical Specialties) experienced а +13.19% price change this week, while RCEL (@Medical Specialties) price change was +7.38% for the same time period.

The average weekly price growth across all stocks in the @Medical Specialties industry was +4.80%. For the same industry, the average monthly price growth was -6.16%, and the average quarterly price growth was -2.09%.

Reported Earning Dates

BLFS is expected to report earnings on Aug 07, 2025.

RCEL is expected to report earnings on Aug 07, 2025.

Industries' Descriptions

@Medical Specialties (+4.80% weekly)

Medical specialties are companies that make equipment used by the health care industry. Equipment manufactured and distributed by these companies include dialysis machines, blood analysis equipment, surgical equipment, dental instruments, and diagnostic tools, among other items. Large companies typically aim to produce and distribute high-quality products across a broad market spectrum. Smaller firms are more likely to specialize in a particular market segment. Due to the industry’s close association with medical treatments, they typically have low sensitivity to macroeconomic fluctuations. Within this industry, Abbott Laboratories, Medtronic Plc and Thermo Fisher Scientific Inc. are some of the companies with multi-billion market capitalizations in the U.S. stock markets.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
BLFS($811M) has a higher market cap than RCEL($399M). BLFS YTD gains are higher at: -4.468 vs. RCEL (-22.734). RCEL has higher annual earnings (EBITDA): -33.54M vs. BLFS (-45.24M). RCEL has more cash in the bank: 89.1M vs. BLFS (51.7M). RCEL (42.4M) and BLFS (42.7M) have identical debt. BLFS has higher revenues than RCEL: BLFS (143M) vs RCEL (50.1M).
BLFSRCELBLFS / RCEL
Capitalization811M399M203%
EBITDA-45.24M-33.54M135%
Gain YTD-4.468-22.73420%
P/E Ratio238.10N/A-
Revenue143M50.1M285%
Total Cash51.7M89.1M58%
Total Debt42.7M42.4M101%
FUNDAMENTALS RATINGS
BLFS vs RCEL: Fundamental Ratings
BLFS
RCEL
OUTLOOK RATING
1..100
1164
VALUATION
overvalued / fair valued / undervalued
1..100
95
Overvalued
66
Overvalued
PROFIT vs RISK RATING
1..100
71100
SMR RATING
1..100
9198
PRICE GROWTH RATING
1..100
5944
P/E GROWTH RATING
1..100
12100
SEASONALITY SCORE
1..100
50n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

RCEL's Valuation (66) in the null industry is in the same range as BLFS (95) in the Medical Specialties industry. This means that RCEL’s stock grew similarly to BLFS’s over the last 12 months.

BLFS's Profit vs Risk Rating (71) in the Medical Specialties industry is in the same range as RCEL (100) in the null industry. This means that BLFS’s stock grew similarly to RCEL’s over the last 12 months.

BLFS's SMR Rating (91) in the Medical Specialties industry is in the same range as RCEL (98) in the null industry. This means that BLFS’s stock grew similarly to RCEL’s over the last 12 months.

RCEL's Price Growth Rating (44) in the null industry is in the same range as BLFS (59) in the Medical Specialties industry. This means that RCEL’s stock grew similarly to BLFS’s over the last 12 months.

BLFS's P/E Growth Rating (12) in the Medical Specialties industry is significantly better than the same rating for RCEL (100) in the null industry. This means that BLFS’s stock grew significantly faster than RCEL’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
BLFSRCEL
RSI
ODDS (%)
Bullish Trend 2 days ago
77%
N/A
Stochastic
ODDS (%)
Bullish Trend 2 days ago
83%
Bearish Trend 2 days ago
75%
Momentum
ODDS (%)
Bullish Trend 2 days ago
79%
Bullish Trend 2 days ago
72%
MACD
ODDS (%)
Bullish Trend 2 days ago
73%
Bullish Trend 2 days ago
74%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
82%
Bullish Trend 2 days ago
76%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
85%
Bullish Trend 2 days ago
75%
Advances
ODDS (%)
Bullish Trend 2 days ago
79%
Bullish Trend 2 days ago
74%
Declines
ODDS (%)
Bearish Trend 4 days ago
84%
Bearish Trend 14 days ago
79%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
82%
Bullish Trend 2 days ago
74%
Aroon
ODDS (%)
Bearish Trend 2 days ago
78%
N/A
View a ticker or compare two or three
Ad is loading...
BLFS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
RCEL
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
MIRGX36.54N/A
N/A
MFS Massachusetts Inv Gr Stk R2
INUTX36.18N/A
N/A
Columbia Dividend Opportunity A
TMMAX17.16N/A
N/A
SEI Tax-Managed Mgd Volatility F (SIMT)
TGRYX11.61N/A
N/A
TCW Global Real Estate N
SIMYX12.01N/A
N/A
SEI Tax-Managed Intl Mgd Vol Y (SIMT)

RCEL and

Correlation & Price change

A.I.dvisor indicates that over the last year, RCEL has been loosely correlated with MRCHF. These tickers have moved in lockstep 38% of the time. This A.I.-generated data suggests there is some statistical probability that if RCEL jumps, then MRCHF could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To RCEL
1D Price
Change %
RCEL100%
+1.54%
MRCHF - RCEL
38%
Loosely correlated
N/A
INMD - RCEL
35%
Loosely correlated
+3.53%
BLFS - RCEL
34%
Loosely correlated
+1.85%
MBOT - RCEL
33%
Loosely correlated
+16.83%
SGHT - RCEL
33%
Loosely correlated
+2.49%
More